Clinical Trial Update: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the long-term safety of lacosamide versus carbamazepine controlled-release as initial monotherapy in adults with epil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Carbamazepine CR (carbamazepine)
• Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Epilepsy, Monotherapy | Phase 3 | Status: COMPLETED | Results posted: 2017-08-02